Consolidated Statements of Cash Flow - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net Loss	$ (14,556,680)	$ (11,709,412)
Adjustments to reconcile Net Loss to Net Cash used in operations:
Depreciation and amortization	4,455,962	599,863
Debt discount amortization	115,533	151,856
Stock grants	534,929	703,030
Stock for services	352,300	22,350
Contingent consideration fair value	(190,377)
Employee stock awards	901,526	1,172,974
Reduction to right of use asset	381,140
Allowance for doubtful accounts	(67,117)	106,320
Stock and warrants for promissory note conversion		358,000
Loss on purchase		2,118,154
Changes in Current Assets and Liabilities
Accounts receivable	(1,679,887)	(131,113)
Due to (from) related parties	3,758	(5,361)
Inventories	364,524	(2,367,591)
Prepaid expenses	148,982	215,489
Deposits	(178,287)	(12,734)
Accounts payable	3,277,010	1,440,879
Accrued liabilities	1,106,411	42,289
Operating lease liability	(329,162)
Net cash used in operating activities	(5,359,435)	(7,295,007)
Cash flows from investing activities
Purchase of equipment	(462,385)	(2,291,907)
Jagemann acquisition		(7,000,000)
Acquisition deposit		(250,000)
Net cash used in investing activities	(462,385)	(9,541,907)
Cash flow from financing activities
Proceeds from note payable related party issued	819,731
Payments on note payable - related party	(1,885,000)	(500,000)
Payments on insurance premium note payment	(466,421)	(191,275)
Contingent consideration payment	(300,000)	(50,000)
Proceeds from convertible promissory note	2,171,000	1,534,000
Sale of common stock	2,465,540	10,903,930
Purchase of common stock		(124,000)
Proceeds from factoring liability	9,747,281
Payments on factoring liability	(7,741,302)
Common stock issued for exercised warrants		4,767,625
Common stock issuance costs	(285,981)	(1,704,563)
Net cash provided by financing activities	4,524,848	14,635,717
Net decrease in cash	(1,296,972)	(2,200,397)
Cash, beginning of period	2,181,246	4,381,643
Cash, end of period	884,274	2,181,246
Supplemental cash flow disclosures
Cash paid during the period for - Interest	531,274	240,523
Cash paid during the period for - Income taxes
Non-cash investing and financing activities:
Convertible promissory note	(318,226)
Convertible promissory note conversion	318,226
Insurance premium note payment	565,548	321,966
Prepaid expenses	(565,548)	(321,966)
Right of use assets - operating leases	(3,771,873)
Rent expense	(41,013)
Operating lease liability	3,812,886
Notes payable related party	(2,596,200)
Accounts receivable	(31,924)
Deposits	(9,250)
Equipment	1,871,306
Other Intangible Assets	766,068
Additional paid-in-capital		(11)
Common stock		11
Issuance of common stock		4,624,005
Contingent consideration payable		1,250,000
Patent acquisition		(5,874,005)
Issuance of common stock		7,381,846
Note payable - related party		10,400,000
Acquired Intangible Assets		(5,912,305)
Acquired Equipment		(11,869,541)
Convertible promissory note		(1,410,000)
Accrued Liabilities		(52,065)
Convertible promissory note conversion		1,462,065
Total non-cash investing and financing activities